Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes
- PMID: 12818695
- DOI: 10.1016/s0014-2999(03)01817-x
Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes
Abstract
Cytisine very potently binds and activates the alpha 3 beta 4 and alpha 7 nicotinic subtypes, but only partially agonises the alpha 4 beta 2 subtype. Although with a lower affinity than cytisine, new cytisine derivatives with different substituents on the basic nitrogen (CC1-CC8) bind to both the heteromeric and homomeric subtypes, with higher affinity for brain [3H]epibatidine receptors. The cytisine derivatives were tested on the Ca(2+) flux of native or transfected cell lines expressing the rat alpha 7, or human alpha 3 beta 4 or alpha 4 beta 2 subtypes using Ca(2+) dynamics in conjunction with a fluorescent image plate reader. None elicited any response at doses of up to 30-100 microM, but all inhibited agonist-induced responses. Compounds CC5 and CC7 were also electrophysiologically tested on oocyte-expressed rat alpha 4 beta 2, alpha 3 beta 4 and alpha 7 subtypes. CC5 competitively antagonised the alpha 4 beta 2 and alpha 3 beta 4 subtypes with similar potency, whereas CC7 only partially agonised them with maximum responses of respectively 3% and 11% of those of 1 mM acetylcholine. Neither compound induced any current in the oocyte-expressed alpha 7 subtype, and both weakly inhibited acetylcholine-induced currents. Adding chemical groups of a different class or size to the basic nitrogen of cytisine leads to compounds that lose full agonist activity on the alpha 3 beta 4 and alpha 7 subtypes.
Similar articles
-
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.Br J Pharmacol. 2005 Dec;146(8):1096-109. doi: 10.1038/sj.bjp.0706434. Br J Pharmacol. 2005. PMID: 16273122 Free PMC article.
-
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.J Pharmacol Exp Ther. 1998 May;285(2):777-86. J Pharmacol Exp Ther. 1998. PMID: 9580626
-
Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.Mol Pharmacol. 2006 Sep;70(3):947-59. doi: 10.1124/mol.106.025338. Epub 2006 May 25. Mol Pharmacol. 2006. PMID: 16728647
-
Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.Nat Prod Rep. 2012 May 1;29(5):555-67. doi: 10.1039/c2np00100d. Epub 2012 Feb 27. Nat Prod Rep. 2012. PMID: 22367109 Review.
-
Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities.Farmaco. 2003 Mar;58(3):265-77. doi: 10.1016/S0014-827X(03)00017-X. Farmaco. 2003. PMID: 12620422 Review.
Cited by
-
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.Br J Pharmacol. 2013 Feb;168(4):835-49. doi: 10.1111/j.1476-5381.2012.02204.x. Br J Pharmacol. 2013. PMID: 22957729 Free PMC article.
-
The cytisine derivatives, CC4 and CC26, reduce nicotine-induced conditioned place preference in zebrafish by acting on heteromeric neuronal nicotinic acetylcholine receptors.Psychopharmacology (Berl). 2014 Dec;231(24):4681-93. doi: 10.1007/s00213-014-3619-x. Epub 2014 May 27. Psychopharmacology (Berl). 2014. PMID: 24862365
-
Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.Psychopharmacology (Berl). 2014 May;231(9):1975-85. doi: 10.1007/s00213-013-3340-1. Epub 2013 Dec 6. Psychopharmacology (Berl). 2014. PMID: 24311357
-
Nicotine-modulated subunit stoichiometry affects stability and trafficking of α3β4 nicotinic receptor.J Neurosci. 2013 Jul 24;33(30):12316-28. doi: 10.1523/JNEUROSCI.2393-13.2013. J Neurosci. 2013. PMID: 23884938 Free PMC article.
-
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.Br J Pharmacol. 2005 Dec;146(8):1096-109. doi: 10.1038/sj.bjp.0706434. Br J Pharmacol. 2005. PMID: 16273122 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous